HopeStage
Back to all studies
CompletedNCT00873249

Daily text reminders and antipsychotic medication adherence in schizophrenia

About this titleRead the official source — NCT00873249
Observational studyAges 18+Spain
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria applied.

Listed locations
Alicante and 24 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2009
Recruitment status
Completed
Enrollment listed in the registry
339
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
Spain
Age range
Over 18 Years
Official registry ID
NCT00873249
Official title
Show the full official title

Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Alicante · Almería · Barcelona

22 more locations
  • Berga
  • Sabadell
  • Burgos
  • Santander
  • Córdoba
  • Granada
  • León
  • Lleida
  • Madrid
  • Málaga
  • Murcia
  • Pamplona
  • Oviedo
  • Palma Mallorca
  • Salamanca
  • Seville
  • Tarragona
  • Toledo
  • Valencia
  • Valladolid
  • Zamora
  • Calatayud

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies